Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein

Next Previous
X
Search
Trial Profile

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Cardiovascular disorders; Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism
  • Focus Pharmacogenomic; Registrational; Therapeutic Use
  • Acronyms JUPITER
  • Sponsors AstraZeneca

    • Most Recent Events

    • 15 Nov 2021 Results of mediation analysis from JUPITER and VITAL studies presented at the American Heart Association Scientific Sessions 2021
    • 29 Jun 2021 Results of secondary analysis presented at the 81st Annual Scientific Sessions of the American Diabetes Association
    • 08 Jan 2021 Results from CANTOS, JUPITER, SPIRE-1, SPIRE-2, and CIRT trials published in the European Heart Journal

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top